摘要
目的·研究低剂量地西他滨对原发免疫性血小板减少症(immune thrombocytopenia,ITP)患者来源的骨髓间充质干细胞(mesenchymal stem cell,MSC)增殖、凋亡等生物学行为的影响。方法·纳入2020年4月—2021年10月上海交通大学医学院附属仁济医院血液科门诊或住院的ITP发病期患者10例,以及10例无骨髓异常的非ITP患者作为对照(normal control,NC),收集骨髓穿刺标本,分离MSC,流式细胞术检测其表面抗原标志物。使用CCK-8试剂盒和EdU细胞增殖检测试剂盒检测及比较ITP患者来源(MSC-ITP)和对照组来源(MSC-NC)的MSC增殖水平差异,并使用微管荧光探针检测细胞形态的变化。使用Hoechst 33258染色观察细胞凋亡情况,采用Annexin V-FITC/PI细胞凋亡双染试剂盒检测细胞凋亡水平。通过不同浓度的地西他滨以不同的时长处理MSC-ITP,探索地西他滨促其增殖的最佳浓度及处理时间。以最佳浓度的地西他滨处理MSC-ITP,观察其对细胞凋亡水平的影响。Western blotting检测细胞凋亡相关通路蛋白的表达,以及地西他滨的影响。结果·与MSC-NC相比,MSC-ITP细胞形态异常,细胞核碎裂、皱缩较多,体外增殖水平减弱,基础凋亡率增加。地西他滨刺激MSC-ITP增殖的最佳工作浓度为2.5μmol/L,最佳处理时间为24 h。2.5μmol/L地西他滨处理MSCITP 24 h后细胞核形态得到改善,细胞核的碎裂和凝聚减少,凋亡率显著降低(P<0.05)。Western blotting结果表明,地西他滨处理后,MSC-ITP中线粒体凋亡通路相关蛋白BAX降低,胱天蛋白酶(caspase3)和cleaved-caspase3减少(均P<0.05)。结论·ITP患者骨髓来源的MSC形态异常,体外增殖水平减弱,基础凋亡率增加;低剂量地西他滨可以促进该细胞增殖,抑制其凋亡;该作用可能是通过线粒体凋亡途径介导的。
Objective·To investigate the effects of low-dose decitabine on the biological behaviors of proliferation and apoptosis of bone marrow mesenchymal stem cells(MSC)derived from the patients with primary immune thrombocytopenia(ITP).Methods·Ten patients with ITP onset who were outpatients or inpatients in the Department of Hematology,Renji Hospital,Shanghai Jiao Tong University School of Medicine,from April 2020 to October 2021 were included,and 10 non-ITP patients without bone marrow abnormalities were included as controls(normal control,NC).The bone marrow aspiration specimens were collected,MSCs were isolated,and flow cytometry was used to detect their surface antigenic markers.Differences in MSC proliferation levels between the ITP patients(MSC-ITP)and the controls(MSC-NC)were detected by using the CCK-8 kit and the EdU cell proliferation assay kit,and the changes in cell morphology were detected by using microtubule fluorescent probes.Apoptosis was observed by using Hoechst 33258 staining,and the level of apoptosis was detected by using Annexin V-FITC/PI apoptosis double-staining kit.The optimal concentration and treatment time of decitabine to promote the proliferation of MSC-ITP were explored by treatment with different concentrations and different durations.Western blotting was performed to detect the expression of apoptosis-related proteins and the effect of decitabine.Results·Compared with MSC-NC,MSC-ITP showed abnormal morphology,more nuclear fragmentation and crinkling,reduced proliferation level in vitro,and increased basal apoptosis rate.The optimal working concentration of decitabine to stimulate MSC-ITP proliferation was 2.5μmol/L,and the optimal treatment time was 24 h.After 2.5μmol/L decitabine treating MSC-ITP for 24 h,cell nuclear morphology was improved,nuclei fragmentation and coalescence were reduced,and apoptosis rate was significantly decreased(P<0.05).Western blotting results showed that BAX,a mitochondrial apoptosis pathway-related protein,cystatin protease 3(caspase3)and cleaved-caspa
作者
王昕芃
王君颖
蔡佳翌
付婉彬
钟华
WANG Xinpeng;WANG Junying;CAI Jiayi;FU Wanbing;ZHONG Hua(Department of Hematology,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China;Central Laboratory,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China)
出处
《上海交通大学学报（医学版）》
CAS
CSCD
北大核心
2022年第6期758-767,共10页
Journal of Shanghai Jiao tong University:Medical Science
基金
上海交通大学医学院附属仁济医院南院临床多学科合作共建项目(2014MDT01-07)。
